Hong Kong Entertainment Stock News

Hua Hong Grace Semiconductor was added to the Hang Seng Index on 7 September 2026, increasing its relevance within Hong Kong’s benchmark equity universe. This index inclusion sharpens attention on how Hua Hong Grace Semiconductor’s capital intensive expansion and mature node focus align with broader semiconductor demand trends. We will examine how Hua Hong Grace Semiconductor's index inclusion interacts with its capacity heavy investment narrative and demand risk. Scan how Hua Hong Grace...

Earnings jump and higher proposed dividend put Sun Hung Kai Properties in focus Sun Hung Kai Properties (SEHK:16) moved into the spotlight after reporting full year 2026 results that showed higher sales and net income, alongside a proposed increase in its final ordinary dividend. The group reported HK$94,194 million in sales for the year ended 30 June 2026, compared with HK$79,721 million a year earlier. Net income came in at HK$21,426 million, up from HK$19,277 million in the prior...

SSY Group secured past approvals from China’s National Medical Products Administration for Letermovir Injection and Diltiazem Hydrochloride Tablets, expanding its perioperative and cardiovascular treatment range using its existing strength in intravenous infusions. The combination of a CMV prevention therapy for transplant patients and a chronic cardiovascular medicine deepens SSY Group’s presence in high-acuity hospital settings, which can influence capacity utilization and product mix...

Power Assets Holdings (SEHK:6) has drawn investor attention after its stock closed at HK$60.15, with recent returns mixed over the past week, month, and past 3 months, yet materially stronger over longer periods. Recent trading shows that momentum in the Power Assets Holdings share price has cooled in the near term, yet the stock still carries a 7.03% 3 month share price return and a 22.30% 1 year total shareholder return. This points to longer term strength despite short term...

The market has been punishing IMPACT Therapeutics, with the share price down about 10% over the past week and close to 70% over three months. Yet the headline from these results is blunt: this is still a high-growth, loss-making biotech, and the revenue line is doing almost all the talking. H1 2026 revenue reached C¥105.19 million, well above the prior period, while the business still reported a net loss of C¥90.81 million. That mix of rapid sales expansion and continued red ink, sitting on a...

Amidst escalating geopolitical tensions and rising oil prices, global markets have faced downward pressure, with major indices reflecting investor concerns over inflation and monetary policy shifts. In such a volatile landscape, identifying stocks that balance potential growth with financial resilience is crucial. Penny stocks, though often overlooked as a niche investment category, can still provide intriguing opportunities when backed by robust financials. This article will explore several...

Over the past year, many CMON Limited ( HKG:1792 ) insiders sold a significant stake in the company which may have...

Trade wars are no longer just headlines. They are quietly reshaping where factories sit, how goods move, and which companies carry more risk when tariffs flare up. That shift creates a real opening for investors who watch how supply chains are rewired rather than only where demand comes from. This article unpacks that story and spotlights 3 stocks from our Nearshoring and Onshoring Industrial Infrastructure screener that appear positively exposed to the latest trade shock. The three stocks...

China Galaxy Securities has delivered a powerful 5 year share price run, even though the stock has fallen sharply over the past year. This puts fresh focus on whether current investors are paying a justified price for its earnings. With that backdrop, the live question is how well the present valuation lines up with what the business is actually earning today. Over the past 5 years, China Galaxy Securities has returned about 127.0%, which puts a lot of past optimism into the current share...

Yue Yuen Industrial (Holdings) reported unaudited net consolidated operating revenue of US$636,647,000 for August 2026 and US$5,217,301,000 for the year to date. The fresh monthly and year to date sales disclosure gives investors a timely read on demand trends and order flow across Yue Yuen Industrial (Holdings)' manufacturing operations. This article now considers how Yue Yuen Industrial (Holdings)' latest unaudited revenue figures may influence the broader investment narrative around the...

CITIC (SEHK:267) has drawn investor interest after its latest trading session, with the share price closing at HK$12.98 and short term performance showing mixed moves over the past week and month. Short term momentum in CITIC has eased, with the share price down 2.63% over the last session and 3.99% over the week. However, a 1-year total shareholder return of 15.59% and triple digit 3-year and 5-year total shareholder returns suggest longer term holders have still seen strong overall...

As the Asian markets navigate a complex landscape marked by geopolitical tensions and fluctuating oil prices, investors are keeping a keen eye on potential opportunities. Penny stocks, though often considered niche investments, can offer unique growth prospects when they are underpinned by solid financial health. This article will explore three such stocks that stand out for their balance sheet strength and potential for long-term success in the current economic climate.

China Coal Energy reported August 2026 data showing commercial coal production and self produced coal sales below the prior year, while several chemical products such as polyethylene and polypropylene recorded higher volumes. The mix of softer coal volumes alongside relatively resilient chemicals output signals shifting demand and capacity use within China Coal Energy's coal and coal chemicals portfolio. In the following sections we examine how China Coal Energy's investment narrative is...

By selling CN¥186m worth of Butong Group ( HKG:6090 ) stock at an average sell price of CN¥34.76 over the last year...

Just because a business does not make any money, does not mean that the stock will go down. For example, Values...

Akeso (SEHK:9926) is back in focus after presenting new overall survival data from its Phase III HARMONi-2 trial of ivonescimab versus pembrolizumab in first-line PD-L1-positive non-small cell lung cancer at WCLC 2026. Akeso’s HK$95.25 share price has drifted lower over the year to date with a decline of 15.93%, yet a 13.53% 3 month share price return and a 3 year total shareholder return of 151.98% suggest long term holders have still seen strong gains as sentiment oscillates around each new...

Venture Global and China Gas Holdings previously announced a 20-year Sales and Purchase Agreement for 0.5 million tonnes per annum of U.S. LNG from 2030, lifting China Gas's contracted LNG offtake with Venture Global to 2.5 million tonnes per year. The additional volumes deepen China Gas Holdings' access to long-term U.S. LNG and support its goal of building an international energy trading platform that links overseas supply with growing demand. We will now examine how China Gas Holdings'...

Chen Lin Education Group Holdings Limited ( HKG:1593 ) insiders who purchased shares in the last 12 months were richly...

As the Asian markets navigate a landscape marked by geopolitical tensions and fluctuating oil prices, investors are keenly observing opportunities that may arise amidst these challenges. Penny stocks, despite their somewhat outdated moniker, continue to attract attention for their potential to offer growth opportunities in smaller or emerging companies. This article will explore three such stocks that not only demonstrate financial resilience but also present intriguing possibilities for...

Last week, you might have seen that China Overseas Land & Investment Limited ( HKG:688 ) released its half-yearly...

Datang International Power Generation (SEHK:991) has drawn fresh attention after a recent price move left the share price at HK$2.645. Investors are weighing this level against the group’s substantial power generation footprint across China. Recent trading tells a mixed story. The 1 day share price return declined 1.67% and the 7 day share price return slipped 2.76%. However, Datang International Power Generation still shows a 30 day share price return of 8.62% and a year to date share price...

Markets are being rewired in real time as fresh transparency rules, tighter investor protections and shifting geopolitics reshape how capital moves across borders. That kind of structural change can reward firms that adapt early and expose laggards that do not. This article unpacks that story and profiles 3 stocks from a Global Exchanges & Market Infrastructure Providers screener that appear particularly exposed to the latest round of regulatory and geopolitical crosswinds. The stocks...

JNBY Design reported full year results to June 30, 2026, with sales of CNY 6,046.26 million and net income of CNY 997.45 million, alongside higher basic and diluted earnings per share from continuing operations compared with the prior year. The company delivered this higher full year profit while also managing board succession, as a key independent director prepares to retire and committee leadership shifts to another independent member. This article examines how JNBY Design's higher full...

The National Medical Products Administration has accepted LongBio Pharma’s Biologics License Application for LP-003, supported by Innovent Biologics (SEHK:1801) subsidiary Altruist Biologics, marking China’s first anti-IgE BLA for seasonal allergic rhinitis. For investors tracking Innovent Biologics, the latest regulatory milestone lands after a mixed stretch in the market, with the share price slipping 1.9% over the last session and 5.2% across the week, yet recording a 26.9% 90 day share...